Full Press Release Details
Media
• August 29, 2024
IRWD Positive Sentiment
Ironwood Pharmaceuticals to Participate in the 2024 Wells Fargo Healthcare Conference
Key Takeaway: Ironwood Pharmaceuticals has announced its participation in the 2024 Wells Fargo Healthcare Conference. This event is significant for the company as it provides an opportunity to engage with investors and industry stakeholders. The conference is expected to enhance Ironwood's visibility in the healthcare sector.
Price reaction · baseline $4.75 (2024-08-28 close) · hit after-hours · clean, no other IRWD news in the window
day 0 close · peak
+7.6%
day 1
+6.5%
day 3
+4.4%
Market Sentiment Analysis
POSITIVE FACTORS
- Ironwood Pharmaceuticals is actively participating in a prominent healthcare conference.
- Engagement in the Wells Fargo Healthcare Conference highlights Ironwood's commitment to investor relations.
- Participation may enhance visibility and networking opportunities for the company.
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+57%
120-day peak, hindsight
Typical move
3.8%
average across 2 past catalysts
Lead asset
IW-3718
Phase 3 · Gastroesophageal Reflux Disease (GERD)
Frequently Asked Questions
What conference will Ironwood Pharmaceuticals attend?
Ironwood Pharmaceuticals will participate in the 2024 Wells Fargo Healthcare Conference.
Why is Ironwood participating in the conference?
Participation allows Ironwood to engage with investors and enhance visibility.